Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong
· Delayed Price · Currency is HKD 0.810
0.00 (0.00%)
Apr 29, 2026, 3:16 PM HKT
HKG:3737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 17.29 | 95.21 | 162.78 | 106.39 | 52.13 | Upgrade
|
| Depreciation & Amortization | 99.15 | 108.13 | 99.48 | 93.58 | 82.46 | Upgrade
|
| Other Amortization | 3.33 | 3.29 | 2.6 | 2.8 | 2.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.34 | 1.2 | -0.43 | -0.69 | -0.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.53 | 3.9 | -3.61 | -2.43 | 40.44 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.76 | 4.1 | 0.47 | -0.16 | 0.44 | Upgrade
|
| Other Operating Activities | -10.66 | -1.16 | -15.37 | -3.04 | -27.84 | Upgrade
|
| Change in Accounts Receivable | -16.78 | -119.74 | -18.22 | -13.59 | 10.03 | Upgrade
|
| Change in Inventory | 59.13 | -22.4 | -10.65 | -59.79 | -21.03 | Upgrade
|
| Change in Accounts Payable | -34.36 | 104.99 | 1.19 | 68.95 | 10.39 | Upgrade
|
| Change in Unearned Revenue | 2.12 | 4.88 | 8.67 | 10.53 | 10.57 | Upgrade
|
| Change in Other Net Operating Assets | 62.91 | -0.92 | -125.39 | 82.03 | 18.31 | Upgrade
|
| Operating Cash Flow | 179.7 | 181.48 | 101.5 | 284.57 | 178.38 | Upgrade
|
| Operating Cash Flow Growth | -0.98% | 78.79% | -64.33% | 59.53% | 91.44% | Upgrade
|
| Capital Expenditures | -35.22 | -140.76 | -169.18 | -88.41 | -185.85 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.32 | 3.82 | 17.1 | 21.83 | 2.53 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.05 | -1.1 | -2.25 | -0.74 | -2.01 | Upgrade
|
| Investment in Securities | -21.22 | 3.24 | -55.45 | 70.95 | 22.7 | Upgrade
|
| Other Investing Activities | 4.03 | 14.73 | 7.02 | 9.76 | 26.66 | Upgrade
|
| Investing Cash Flow | -51.14 | -120.06 | -202.76 | 13.38 | -135.98 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 123.87 | Upgrade
|
| Long-Term Debt Issued | 58.9 | 52.36 | 49.67 | 10.5 | - | Upgrade
|
| Total Debt Issued | 58.9 | 52.36 | 49.67 | 10.5 | 123.87 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -145.54 | Upgrade
|
| Long-Term Debt Repaid | -140.67 | -83.65 | -88.63 | -78.67 | -45.41 | Upgrade
|
| Total Debt Repaid | -140.67 | -83.65 | -88.63 | -78.67 | -190.96 | Upgrade
|
| Net Debt Issued (Repaid) | -81.77 | -31.29 | -38.96 | -68.16 | -67.09 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 30.04 | Upgrade
|
| Repurchase of Common Stock | - | -3.57 | - | - | -4.38 | Upgrade
|
| Common Dividends Paid | -38.55 | -23.14 | -116.15 | - | - | Upgrade
|
| Other Financing Activities | -0.38 | -0.73 | 0.49 | 0.02 | 0.6 | Upgrade
|
| Financing Cash Flow | -120.7 | -58.74 | -154.62 | -68.14 | -40.83 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.06 | 0.05 | -0.77 | -2.18 | 0.78 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.52 | - | - | - | - | Upgrade
|
| Net Cash Flow | 7.32 | 2.74 | -256.64 | 227.63 | 2.35 | Upgrade
|
| Free Cash Flow | 144.47 | 40.72 | -67.68 | 196.17 | -7.47 | Upgrade
|
| Free Cash Flow Growth | 254.76% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 8.31% | 1.84% | -3.30% | 10.74% | -0.43% | Upgrade
|
| Free Cash Flow Per Share | 0.17 | 0.05 | -0.08 | 0.23 | -0.01 | Upgrade
|
| Cash Interest Paid | 1.95 | 2.63 | 2.61 | 1.92 | 2.67 | Upgrade
|
| Cash Income Tax Paid | 12.62 | 44 | 42.54 | 17.37 | 23.88 | Upgrade
|
| Levered Free Cash Flow | 9.17 | 27.57 | -103.76 | 245.16 | -49.32 | Upgrade
|
| Unlevered Free Cash Flow | 12.53 | 31.94 | -98.84 | 249.26 | -44.89 | Upgrade
|
| Change in Working Capital | 73.02 | -33.2 | -144.41 | 88.13 | 28.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.